Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results
Accelerate Diagnostics (NASDAQ: AXDX) has announced a conference call scheduled for Thursday, August 8, 2024, at 4:30 p.m. Eastern Time to review the company's 2024 second quarter results. Investors and interested parties can access the audio webcast online at ir.axdx.com, with a replay available for 30 days. For those preferring to listen by phone, dial-in options are provided for both U.S. and international participants. A telephone replay will be accessible until August 29, 2024, using specific replay codes for U.S. and international callers.
Accelerate Diagnostics (NASDAQ: AXDX) ha annunciato una conferenza telefonica in programma per giovedì 8 agosto 2024, alle 16:30 ora orientale, per esaminare i risultati del secondo trimestre 2024 della società. Gli investitori e le parti interessate possono accedere alla web diretta audio online su ir.axdx.com, con una replica disponibile per 30 giorni. Per coloro che preferiscono ascoltare per telefono, sono forniti opzioni di accesso sia per i partecipanti statunitensi che internazionali. Una replica telefonica sarà accessibile fino al 29 agosto 2024, utilizzando codici di accesso specifici per i chiamanti statunitensi e internazionali.
Accelerate Diagnostics (NASDAQ: AXDX) ha anunciado una llamada de conferencia programada para el jueves 8 de agosto de 2024, a las 4:30 p.m. hora del este para revisar los resultados del segundo trimestre de 2024 de la compañía. Los inversores y partes interesadas pueden acceder a la transmisión de audio en línea en ir.axdx.com, con una repetición disponible durante 30 días. Para aquellos que prefieren escuchar por teléfono, se proporcionan opciones de conexión tanto para participantes de EE. UU. como internacionales. Una repetición telefónica estará disponible hasta el 29 de agosto de 2024, utilizando códigos de repetición específicos para los llamantes de EE. UU. e internacionales.
Accelerate Diagnostics (NASDAQ: AXDX)는 2024년 8월 8일 목요일, 동부 표준시 기준 오후 4시 30분에 회사의 2024년 2분기 실적을 검토하기 위한 전화 회의를 발표했습니다. 투자자 및 관심 있는 당사자는 ir.axdx.com에서 온라인으로 오디오 웹캐스트에 접근할 수 있으며, 30일 동안 재생이 가능합니다. 전화로 듣기를 원하는 경우, 미국 및 국제 참가자를 위한 다이얼인 옵션이 제공됩니다. 전화 재생은 2024년 8월 29일까지 이용 가능하며, 미국 및 국제 호출자를 위한 특정 재생 코드가 필요합니다.
Accelerate Diagnostics (NASDAQ: AXDX) a annoncé une conférence téléphonique prévue pour jeudi 8 août 2024, à 16h30 heure de l'Est afin d'examiner les résultats du deuxième trimestre 2024 de l'entreprise. Les investisseurs et les parties intéressées peuvent accéder à la diffusion audio en ligne sur ir.axdx.com, avec une rediffusion disponible pendant 30 jours. Pour ceux qui préfèrent écouter par téléphone, des options de connexion sont proposées pour les participants américains et internationaux. Une rediffusion téléphonique sera accessible jusqu'au 29 août 2024, à l'aide de codes de rediffusion spécifiques pour les appelants américains et internationaux.
Accelerate Diagnostics (NASDAQ: AXDX) hat eine Telefonkonferenz für Donnerstag, den 8. August 2024, um 16:30 Uhr Eastern Time angekündigt, um die Ergebnisse des zweiten Quartals 2024 des Unternehmens zu überprüfen. Investoren und interessierte Parteien können den Audio-Webcast online unter ir.axdx.com abrufen, wobei eine Wiederholung für 30 Tage verfügbar ist. Für diejenigen, die lieber telefonisch teilnehmen möchten, stehen Dial-in-Optionen für sowohl US-amerikanische als auch internationale Teilnehmer zur Verfügung. Eine Telefonwiederholung ist bis zum 29. August 2024 zugänglich, wobei spezifische Wiederholungscodes für US-amerikanische und internationale Anrufer erforderlich sind.
- None.
- None.
To listen to the audio webcast online, visit ir.axdx.com. A replay of the audio webcast will be available for 30 days.
To listen by phone, dial +1.877.883.0383 and enter the Elite Entry Number: 9884567. International participants may dial +1.412.902.6506. Please dial in 10-15 minutes prior to the start of the conference.
A replay of the call will be available by telephone at +1.877.344.7529 (
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and "ACCELERATE PHENO TEST" and "ACCELERATE WAVE" and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc.
For more information about the company, its products and technology, or recent publications, visit axdx.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-scheduled-call-to-review-2024-second-quarter-results-302218055.html
SOURCE Accelerate Diagnostics, Inc.
FAQ
When is Accelerate Diagnostics (AXDX) hosting its Q2 2024 earnings call?
How can investors access Accelerate Diagnostics' (AXDX) Q2 2024 earnings call?
Until when will the replay of Accelerate Diagnostics' (AXDX) Q2 2024 earnings call be available?
What is the Elite Entry Number for Accelerate Diagnostics' (AXDX) Q2 2024 earnings call?
